{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:34:48Z","timestamp":1776940488387,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.metabol.2012.07.013","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T00:22:16Z","timestamp":1346718136000},"page":"275-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Direct renin inhibition modulates insulin resistance in caveolin-1-deficient mice"],"prefix":"10.1016","volume":"62","author":[{"given":"Somlak","family":"Chuengsamarn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda E.","family":"Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander W.","family":"Krug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose R.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail K.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon H.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luminita H.","family":"Pojoga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2012.07.013_bb0005","doi-asserted-by":"crossref","first-page":"R974","DOI":"10.1152\/ajpregu.00147.2007","article-title":"Improvement of insulin sensitivity by antagonism of the renin\u2013angiotensin system","volume":"293","author":"Henriksen","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0010","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0015","first-page":"713","article-title":"Insulin resistance and cardiovascular disease","volume":"86","author":"McFarlane","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.07.013_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.coph.2008.01.003","article-title":"Current concepts: renin inhibition in the treatment of hypertension","volume":"8","author":"Gradman","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0025","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/HJH.0b013e32833bc420","article-title":"Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice","volume":"28","author":"Iwai","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2012.07.013_bb0030","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ndt\/gfq579","article-title":"Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db\/db mice","volume":"26","author":"Kang","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2012.07.013_bb0035","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1210\/en.2008-1391","article-title":"Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression","volume":"150","author":"Lastra","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2012.07.013_bb0040","doi-asserted-by":"crossref","first-page":"E1288","DOI":"10.1210\/jc.2010-2738","article-title":"Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension","volume":"96","author":"Pojoga","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.07.013_bb0045","doi-asserted-by":"crossref","first-page":"C222","DOI":"10.1152\/ajpcell.00006.2003","article-title":"Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue","volume":"285","author":"Cohen","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0050","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1124\/mi.3.8.445","article-title":"The biology of caveolae: lessons from caveolin knockout mice and implications for human disease","volume":"3","author":"Hnasko","year":"2003","journal-title":"Mol Interv"},{"key":"10.1016\/j.metabol.2012.07.013_bb0055","doi-asserted-by":"crossref","first-page":"H1776","DOI":"10.1152\/ajpheart.00661.2009","article-title":"Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice","volume":"298","author":"Pojoga","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0060","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1210\/en.2009-0514","article-title":"Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II","volume":"151","author":"Pojoga","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2012.07.013_bb0065","doi-asserted-by":"crossref","first-page":"H1258","DOI":"10.1152\/ajpheart.01014.2007","article-title":"Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice","volume":"294","author":"Pojoga","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2012.07.013_bb0075","first-page":"E487","article-title":"Dissociation in plasma renin and adrenal ANG II and aldosterone responses to sodium restriction in rats","volume":"261","author":"Menachery","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.metabol.2011.06.007","article-title":"Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen\u2013Rosenthal diabetic hypertensive rats","volume":"61","author":"Younis","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.07.013_bb0085","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.metabol.2009.11.013","article-title":"Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen\u2013Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation","volume":"59","author":"Younis","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.07.013_bb0090","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2012.07.013_bb0095","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1210\/en.2008-0070","article-title":"Renin inhibition attenuates insulin resistance, oxidative stress, and pancreatic remodeling in the transgenic Ren2 rat","volume":"149","author":"Habibi","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2012.07.013_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2011.04.009","article-title":"Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat","author":"Manrique","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.07.013_bb0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1507\/endocrj.48.81","article-title":"Clinical significance of the insulin resistance index as assessed by homeostasis model assessment","volume":"48","author":"Ikeda","year":"2001","journal-title":"Endocr J"},{"key":"10.1016\/j.metabol.2012.07.013_bb0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00125-009-1575-5","article-title":"Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes","volume":"53","author":"Dong","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2012.07.013_bb0115","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1152\/ajpregu.00448.2011","article-title":"Chronic renin inhibition with aliskiren improves glucose tolerance, insulin sensitivity, and skeletal muscle glucose transport activity in obese Zucker rats","volume":"302","author":"Marchionne","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0120","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.84.10.5999","volume":"84","author":"Ozata","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.07.013_bb0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF00315543","article-title":"Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension","volume":"44","author":"de Courten","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00265901","article-title":"Unaltered insulin sensitivity during calcium channel blockade with amlodipine","volume":"41","author":"Ferrari","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0135","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1582-4934.2008.00667.x","article-title":"The role of caveolae and caveolin 1 in calcium handling in pacing and contraction of mouse intestine","volume":"13","author":"Daniel","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2012.07.013_bb0140","first-page":"180","article-title":"Skeletal phenotype of mice with a null mutation in Cav 1.3 L-type calcium channel","volume":"10","author":"Li","year":"2010","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.metabol.2012.07.013_bb0145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.107.108845","article-title":"Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats","volume":"52","author":"Feldman","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2012.07.013_bb0150","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2006.11.032","article-title":"Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension","volume":"49","author":"Oh","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2012.07.013_bb0155","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1291\/hypres.29.997","article-title":"Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension","volume":"29","author":"Kushiro","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1016\/j.metabol.2012.07.013_bb0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jhh.2010.38","article-title":"Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome","volume":"25","author":"Krone","year":"2011","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.metabol.2012.07.013_bb0165","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.CIR.0000156466.02908.ED","article-title":"Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients","volume":"111","author":"Gradman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2012.07.013_bb0170","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.HYP.0000101688.17370.87","article-title":"Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren","volume":"42","author":"Stanton","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2012.07.013_bb0175","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00125-005-1680-z","article-title":"A genetic and physiological study of impaired glucose homeostasis control in C57BL\/6J mice","volume":"48","author":"Toye","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2012.07.013_bb0180","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/db10-1032","article-title":"Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy","volume":"59","author":"Rizza","year":"2010","journal-title":"Diabetes"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512002764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512002764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:59:02Z","timestamp":1758427142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049512002764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0026049512002764"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2012.07.013","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct renin inhibition modulates insulin resistance in caveolin-1-deficient mice","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2012.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}